Objective: Visceral artery aneurysms (VAAs) are rare but often repaired because of dire consequences of rupture. This is a population-based evaluation of chronologic trends in management, risk factors, and outcomes of endovascular and open therapy. 2 per 10 million (P < .001). Endovascular patients were more likely to have been treated at urban teaching hospitals (77.1% vs 61.8%; P < .0001); to have higher proportions of renal failure (7.6% vs 4.9%; P ¼ .02), liver disease (11.3% vs 6.6%; P < .001), alcohol abuse (13.1% vs 3.6%; P < .001), chronic blood loss anemia (4.5% vs 1.6%; P < .001), metastatic cancer (2.7% vs 0.8%; P ¼ .003), solid tumor without metastases (3.6% vs 2.0%; P < .037), and weight loss (9.8% vs 5.2%; P < .001); and less likely to have had elective admission (28.9% vs 59.8%; P < .0001). In-hospital mortality (4.1% vs 4.5%; P ¼ .618) and overall complication rates (37.8% vs 38.8%; P ¼ .688) were similar between groups; however, pulmonary complications were decreased for endovascular patients (10
Results: There were 9260 interventions for VAAs from 2003 to 2013, including 5166 endovascular and 4094 open. Endovascular repairs increased from 5.3 to 24.7 per 10 million U.S. population (P < .001), surpassing open repairs in 2008, which decreased from 14.3 to 9.2 per 10 million (P < .001). Endovascular patients were more likely to have been treated at urban teaching hospitals (77.1% vs 61.8%; P < .0001); to have higher proportions of renal failure (7.6% vs 4.9%; P ¼ .02), liver disease (11.3% vs 6.6%; P < .001), alcohol abuse (13.1% vs 3.6%; P < .001), chronic blood loss anemia (4.5% vs 1.6%; P < .001), metastatic cancer (2.7% vs 0.8%; P ¼ .003), solid tumor without metastases (3.6% vs 2.0%; P < .037), and weight loss (9.8% vs 5.2%; P < .001); and less likely to have had elective admission (28.9% vs 59.8%; P < .0001). In-hospital mortality (4.1% vs 4.5%; P ¼ .618) and overall complication rates (37.8% vs 38.8%; P ¼ .688) were similar between groups; however, pulmonary complications were decreased for endovascular patients (10.6% vs 19.7%; P < .001). Endovascular patients had shorter hospital stays (6.5 vs 8.7 days; P < .001). Multivariate adjustment for mortality predictors, including coagulopathy (odds ratio [OR], 4.34; confidence interval [CI], 2.56-7.35; P < .001), liver disease (OR, 2.25; CI, 1.25-4.07; P ¼ .01), fluid and electrolyte disorders (OR, 2.84; CI, 1.73-4.66; P < .001), and solid tumor without metastases (OR, 2.81; CI, 1.10-7.18; P ¼ .03), showed that open treatment was associated with increased mortality (OR, 1.70; CI, 1.03-2.81; P ¼ .04). Analysis of overall complications revealed that open treatment was again associated with increased complications (OR, 1.78; CI, 1.43-2.21; P < .001).
Conclusions: Endovascular VAA repairs are increasing. Despite patients' having worse comorbidities and more nonelective admissions, endovascular therapy appears to be associated with decreased mortality and complications and shorter hospital stays. (J Vasc Surg 2017; 66:195-201.) Visceral artery aneurysms (VAAs) are an exceptionally rare disease entity with a reported incidence of only 0.1% to 2% in the general population. 1 Most of these VAAs are asymptomatic at the time of diagnosis and found incidentally on noninvasive imaging. In spite of their rarity, their diagnosis can represent severe implications for management. Reported outcomes for VAAs are highly variable; however, ruptured VAAs have reported mortality rates ranging between 2.3% 2 and 28.6%, 3 depending on operative approach and location. For childbearing women, rupture can be more common and particularly dire. Rupture rates may be up to 50% in pregnancy, with maternal and fetal mortality rates of 75% and 95%, respectively. 1 Historically, open repair of these aneurysms has been the "gold standard," with excellent longterm results. It typically involves a midline laparotomy and carries significant morbidity. Endovascular repair with techniques such as stenting and coil embolization has become increasingly reported during the past two decades, with improving short-term morbidity and mortality but at the cost of increased reintervention rates. 4 Because of the rarity of VAAs, these data predominantly come from small case series and high-volume singlecenter experiences, resulting in the variable reported outcomes. To our knowledge, the largest reported series included 261 patients with 181 patients repaired. 3 These data may not be reflective of the general population. This study aimed to conduct a large population-based analysis of open and endovascular repairs of VAAs to characterize changes in operative approaches to these aneurysms during the past decade and to compare the outcomes between open and endovascular treatment with the hypothesis that endovascularly treated patients will have decreased complications.
METHODS
Data source. Data were collected from the Agency for Healthcare Research and Quality (AHRQ) National Inpatient Sample (NIS) database for the years 2003 to 2013 to create a contemporary cohort relevant to current patient care. The NIS database is the largest all-payer inpatient care database in the United States. The NIS contains a sample of >7 million hospital discharge records taken from >4000 participating hospitals, which is equal to approximately 20% of the total discharges from U.S. community hospitals, for each data year. This excludes rehabilitation and long-term acute care hospitals. Sampling weights are provided with each of these data points to facilitate the production of national estimates, overall approximately 35 million discharges per year, and to calculate the variance of estimates. The sampling weights are applied to the entire analysis. The NIS underwent a redesign starting with data from the year 2012, with a new sampling strategy to generate more precise estimates. To account for this change in analyses spanning 2012 and earlier NIS data, new sampling weights supplied by the AHRQ are used for data before 2012. Data include International Classification of Diseases, Ninth Revision (ICD-9) diagnosis and procedure codes relatable to morbidity and mortality, hospital characteristics, and cost metrics. Individual cases in the NIS contain inpatient, discharge-specific data in contrast to patient-specific data. Therefore, data on baseline characteristics and outcomes can be obtained only per inpatient visit and not characterized chronologically or longitudinally. For privacy protection, characteristics or outcomes with case numbers <10 may not be published. Any such characteristics or outcomes for which either group had <10 cases were removed from this report. This study was presented to the Yale University Institutional Review Board and was determined not to require review or approval as the NIS database contains only deidentified data without protected health information. Baseline data including age older than 60 years, race, sex, treatment in a teaching hospital, and elective admission as well as 29 pre-recorded AHRQ comorbidity measures (composed of entities such as congestive heart failure, chronic obstructive pulmonary disease, coagulopathy, diabetes with or without complications, hypertension, peripheral vascular disorders, and renal failure) were analyzed and compared between open and endovascular groups.
Postoperative outcomes included in-hospital mortality, disposition, total charges, cardiovascular complications, bleeding complications, pulmonary complications, acute renal failure, wound complications, and urinary tract infections. The ICD-9 codes used to define these complications are available in the Supplementary Table (online only) . Fisher exact test or t-test as appropriate was conducted for all demographic and comorbidity variables comparing mortality vs nonmortality and complication vs noncomplication groups. Endovascular vs open approach and any variables with statistical significance in the univariate analysis of P < .2 were selected for multivariate logistic regression to obtain adjusted odds ratios (ORs) for mortality or any complication. Any complication was defined as an aggregate of all the listed complications in the analysis (including cardiovascular, bleeding, pulmonary, wound, and device complications), acute renal failure, and urinary tract infection. Statistical significance was defined for all tests as a two-sided a level of .05.
RESULTS

Population of patients.
With the weighted analysis as prescribed before, we identified in total 14,054 admissions with a principle diagnosis of VAA. Exclusion of concomitant aortic disease as outlined before resulted in 13,740 cases; 524 cases were associated with both hybrid and endovascular procedures, and 3956 cases were not associated with any intervention. This resulted in a total of 9260 cases for analysis including 4094 open cases and 5166 endovascular cases. Table I . Endovascular patients tended toward treatment at urban teaching hospitals and have greater proportions of comorbidities. Endovascular patients were more likely to be of nonwhite race (24.5% vs 16.2%; P < .0001); however, age, gender, and other demographic data were similar. In terms of treatment setting, endovascular patients were more likely to have been treated at urban teaching hospitals (77.1% vs 61.8%; P < .0001) and less likely to have had elective admission (28.9% vs 59.8%; P < .0001). Regarding comorbidities, endovascular patients had higher proportions of renal failure (7.6% vs 4.9%; P ¼ .02), liver disease (11.3% vs 6.6%; P < .001), alcohol abuse (13.1% vs 3.6%; P < .001), chronic blood loss anemia (4.5% vs 1.6%; P < .001), metastatic cancer (2.7% vs 0.8%; P ¼ .003), solid tumor without metastases (3.6% vs 2.0%; P < .037), and weight loss (9.8% vs 5.2%; P < .001). Other comorbidities were similar between the groups. Open repairs decreased significantly (P < .001), and endovascular and total repairs increased significantly (P < .001).
Outcomes. In-hospital mortality (4.1% vs 4.5%; P ¼ .618) and overall complication rates (37.8% vs 38.8%; P ¼ .688) were similar between groups; however, pulmonary complications were decreased for endovascularly treated patients (10.6% vs 19.7%, P < .001). Cardiovascular, bleeding, wound, and device complications were not significantly different between groups. Endovascular patients had shorter hospital stays (6.5 vs 8.7 days; P < .001). Also, patients were more likely to be discharged to an intermediate care facility after open repair compared with endovascular repair (9.7% vs 6.9%, P ¼ .015). There was no significant difference in the total hospital costs between the two groups (Table II) .
Multivariate logistic regression was undertaken to identify predictors for in-hospital mortality and the development of any complication. 
DISCUSSION
Although uncommon in the general population, VAAs present a challenging disease entity and are becoming increasingly diagnosed and treated. This study demonstrates that the number of overall repairs of VAAs has increased substantially during the last decade and that this was mainly driven by an increase in endovascular repairs. Whereas open repairs still accounted for approximately 30% of repairs in 2013, these repairs are becoming less common in absolute number and proportion. Overall in-hospital mortality and complication rates were similar for endovascular repair patients compared with those of open repair patients. However, endovascularly treated patients exhibited substantially higher rates of baseline comorbidities. As a gross proxy for surgical acuity on admission, 28.9% of endovascular repairs were associated with elective admission compared with 59.8% of open repairs. Consequently, adjusted ORs showed lower mortality and complications associated with an endovascular approach. Endovascularly treated patients also had shorter lengths of stay and similar total charges per admission. These findings of increasing repairs driven by endovascular approaches likely reflect an increase in diagnosis with the increasing use of noninvasive abdominal crosssectional imaging, computed tomography, and magnetic resonance imaging as well as an increase in the inclination of interventionalists to repair VAAs. This has not been formally reported on an epidemiologic scale; however, Hogendoorn et al performed a meta-analysis of existing literature on splenic artery aneurysms and noted a similar trend of only 2% of literature-reported VAA patients managed with endovascular therapy in 1999 but rising to 70% of reported patients in 2010 to 2013. 4 Although the overall number of VAAs treated increased, there was significant decline in open repairs. As endovascular experience and device availability for these aneurysms expand, there will likely be a growing preference to treat by the endovascular approach. Similar to abdominal aortic surgery, whose approaches are founded on many of the same surgical principles, open VAA repair skills may decline in future generations of vascular surgeons without focused opportunities for trainees, also leading to greater preference for endovascular therapies. 5 The data for the management of uncommon diseases such as VAAs often come from high-volume tertiary care referral centers that may not be reflective of the wider vascular community. 8 In contrast, in-hospital mortality rates for this These results in our study and the existing literature supporting the benefits of endovascular repair are likely due to a combination of factors. The more extensive surgical exposure and consequent morbidity of open repair compared with endovascular repair would contribute to increased recovery time and complications, especially pulmonary, as open surgical patients would be more likely to require intubation and postoperative intensive care. Endovascular repair may also allow more direct localization of VAAs in the operating room, especially in the setting of rupture. Extravasation on intraoperative angiography can be more directly visualized in comparison to a small ruptured pseudoaneurysm in a large, bleeding abdominal field.
Whereas our study includes a large sample size of cases, there are important limitations to these data. Although VAAs are a rare disease and often studied under the same umbrella, they comprise a diverse range of locations, sizes, and morphologic features. Because of coding limitations of the ICD-9 system, our analysis cannot discriminate between different types of VAAs except for splenic artery aneurysms. There may be a significant selection bias in this study and others in stating that more easily managed VAAs undergoing endovascular repair have less morbidity than complex VAAs requiring open repair. In addition, further aneurysm-specific data, such as size, morphology, symptomaticity, and rupture, are not available. Data on aneurysm-specific interventions are also lacking. In the case of endovascular interventions, techniques such as stents and coiling cannot be distinguished. Open repairs such as direct primary repairs in contrast to bypass grafting are not differentiated. Because the NIS is limited to in-hospital data, one cannot comment on the durability of any of these repairs. Further study of these traits will require future attention.
To streamline the analysis, several exclusion criteria were used. Cases with concomitant aortic disease were excluded. Such disease may have predisposed patients to a wider array of morbidities in both endovascular and open settings. The NIS is also limited in its ability to characterize cases in which both endovascular and open interventions were performed, so these were excluded. Outside of planned hybrid approaches, conversion from an endovascular to an open approach would seem most conceivable and could be associated with additional morbidity and mortality not taken into account. In spite of this, we would not expect the 9260 cases in this analysis to be significantly affected by the 524 cases excluded for the presence of both open and endovascular procedure codes. Other general limitations of the NIS database include the absence of longitudinal data, including 30-day morbidity and mortality and readmission data. Discriminating between comorbidities and complications may be difficult with this database as ICD-9 diagnosis codes are not necessarily presented in a chronologic order for the admission or with relation to procedures that were performed. The pre-existing AHRQ comorbidity measures that come with the data set can be useful for obtaining baseline characteristics, but these comorbidities can be nonspecific (eg, weight loss) and oblige a deeper understanding of the ICD-9 system for full interpretation. Many of the more specific and relevant baseline characteristics available in single-center studies or vascular-specific registries, such as medications, anticoagulation status, and stage of renal failure, are unavailable.
In spite of these limitations, the data here offer a confirmatory analysis with a large sample size for current theories on treatment of VAAs regarding lower short-term morbidity and mortality for endovascular therapy. A clear epidemiologic trend is demonstrated for the past decade's management of VAAs. Finally, these data should be more generalizable to the vascular surgery and interventionalist community at large.
CONCLUSIONS
Endovascular repair is being increasingly used for VAAs and is associated with lower morbidity and mortality compared with open repair. These results show a potential benefit for endovascular therapy in a larger set of patients than has been previously studied. As this rare disease entity becomes increasingly diagnosed with more advanced noninvasive imaging, management recommendations will become increasingly important.
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